A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer’s disease
Tayyaba Saleem(University of Göttingen), I. Zerr(German Center for Neurodegenerative Diseases), Saima Zafar(German Center for Neurodegenerative Diseases), O. Andreoletti(École Nationale Vétérinaire de Toulouse), Stefan Göbel(German Center for Neurodegenerative Diseases), Carolina Thomas(Universitätsmedizin Göttingen), Sezgi Canaslan(University of Göttingen), Angela da Silva Correia(German Center for Neurodegenerative Diseases), Michael Hoppert(University of Göttingen), Tiago Fleming Outeiro(German Center for Neurodegenerative Diseases), Isidre Ferrer(Universitat de Barcelona), Wiebke Möbius(Max Planck Institute of Experimental Medicine), Peter Hermann(German Center for Neurodegenerative Diseases), Christine Stadelmann(Universitätsmedizin Göttingen), Neelam Younas(German Center for Neurodegenerative Diseases), Matthias Schmitz(German Center for Neurodegenerative Diseases), Elisabeth Dowling Root(Universitätsmedizin Göttingen)
Cited by 1
Related Papers
YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
|Molecular Neurodegeneration|2017|268
Detection of Prion Protein Seeding Activity in Tear Fluids
|New England Journal of Medicine|2023|35
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies
|Science Advances|2021|33
Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo
|Movement Disorders|2021|29
Exploring the effect of telepresence and escapism on consumer post-purchase intention in an immersive virtual reality environment
|Journal of Retailing and Consumer Services|2024|28